Results 51 to 60 of about 150,695 (362)

Diabetic Peripheral Neuropathies

open access: yesAnnals of Internal Medicine, 1987
Diabetic peripheral neuropathies are a group of heterogeneous syndromes with considerable morbidity. At least 50% of diabetic patients develop one or several of these neuropathies within 25 years after the diagnosis. In recent years several pathogenetic mechanisms have been proposed, with the newest findings suggesting a link between several of these ...
openaire   +6 more sources

The Effect of Foot Massage on Decreasing Peripheral Neuropathy Diabetic Complaints in the Patients with Type 2 Diabetes Mellitus

open access: yesJurnal Ners, 2020
Background: Peripheral neuropathy diabetic is a problem that will be experienced by almost all patients with type 2 diabetes mellitus (T2DM). One of the non-pharmacological therapies that can be done to reduce the complaints of peripheral neuropathy ...
Ni Luh Putu Inca Buntari Agustini   +3 more
doaj   +1 more source

Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review

open access: yesCommunications Biology, 2021
Zhang et al. describe metrics for evaluating glycaemic variability (GV) in clinical practice and summarize the role and related mechanisms of GV in diabetic neuropathy, including cardiovascular autonomic neuropathy, diabetic peripheral neuropathy and ...
Xiaochun Zhang   +3 more
doaj   +1 more source

A machine learning-based severity prediction tool for diabetic sensorimotor polyneuropathy using Michigan neuropathy screening instrumentations [PDF]

open access: yesarXiv, 2022
Background: Diabetic Sensorimotor polyneuropathy (DSPN) is a major long-term complication in diabetic patients associated with painful neuropathy, foot ulceration and amputation. The Michigan neuropathy screening instrument (MNSI) is one of the most common screening techniques for DSPN, however, it does not provide any direct severity grading system ...
arxiv  

The Influence of Diabetic Foot Exercise in Sensory Peripheral Neuropathy with Monofilament Test on Diabetes Mellitus Clients

open access: yesJurnal Ners, 2020
Background: Peripheral neuropathy is a long-term complication that attacks the nerves and loses the sensation of protection which affects about 50% of people with diabetes mellitus (DM).
Tintin Sukartini   +2 more
doaj   +1 more source

Artificial Intelligence for Diabetes Case Management: The Intersection of Physical and Mental Health [PDF]

open access: yesInformatics in Medicine Unlocked, 2019, 2018
Diabetes is a major public health problem in the United States, affecting roughly 30 million people. Diabetes complications, along with the mental health comorbidities that often co-occur with them, are major drivers of high healthcare costs, poor outcomes, and reduced treatment adherence in diabetes.
arxiv   +1 more source

Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy

open access: yesNeural Regeneration Research
[INLINE:1] Diabetic peripheral neuropathy is a common complication of diabetes mellitus. Elucidating the pathophysiological metabolic mechanism impels the generation of ideal therapies.
Yaowei Lv   +5 more
doaj   +1 more source

Diabetes Link: Platform for Self-Control and Monitoring People with Diabetes [PDF]

open access: yes, 2020
Diabetes Mellitus (DM) is a chronic disease characterized by an increase in blood glucose (sugar) above normal levels and it appears when human body is not able to produce enough insulin to cover the peripheral tissue demand. Nowadays, DM affects the 8.5% of the world's population and, even though no cure for it has been found, an adequate monitoring ...
arxiv   +1 more source

Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice. [PDF]

open access: yesPLoS ONE, 2016
We previously demonstrated that treatment of diabetic peripheral neuropathy with the short (4 hours) half-life phosphodiesterase 5 (PDE5) inhibitor, sildenafil, improved functional outcome in diabetic db/db mice.
Lei Wang   +7 more
doaj   +1 more source

The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model

open access: yesPharmaceutics, 2022
Little is known regarding the pharmacological properties of extended-release local anesthetics in the setting of diabetic peripheral neuropathy. We investigated and compared the duration of sciatic nerve block following administration of clinically ...
Liljana Markova   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy